Acute rheumatic fever: Clinical aspects and insights into pathogenesis and prevention

Clinical and Applied Immunology Reviews

Volumn 4, Issue 4, 2004, Pages 263-276

  Guzman Cottrill, Judith A ^a   Jaggi, Preeti ^a   Shulman, Stanford T ^a  

^a CHILDREN'S MEMORIAL HOSPITAL   (United States)

Author keywords

Acute rheumatic fever; Anti streptococcal vaccine; M protein; Streptococcus pyogenes

Indexed keywords

ACETYLSALICYLIC ACID; BENZATHINE PENICILLIN; C5A PEPTIDASE; DIGOXIN; DIURETIC AGENT; ERYTHROMYCIN; HALOPERIDOL; HYALURONIC ACID; HYBRID PROTEIN; M PROTEIN; PENICILLIN G; PENICILLIN V; PEPTIDASE; PHENOBARBITAL; PREDNISONE; PROTEINASE; RECOMBINANT PROTEIN; SALICYLIC ACID DERIVATIVE; STREPTOCOCCUS VACCINE; SULFADIAZINE; UNCLASSIFIED DRUG;

CARDITIS; CHILDHOOD DISEASE; CHOREA; CLINICAL FEATURE; CLINICAL TRIAL; HUMAN; INFECTION SENSITIVITY; INFLAMMATORY DISEASE; NONHUMAN; PATHOGENESIS; PHARYNGITIS; PRIORITY JOURNAL; REVIEW; RHEUMATIC FEVER; STREPTOCOCCUS GROUP A; STREPTOCOCCUS INFECTION; VACCINATION;

EID: 1842843020     PISSN: 15291049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cair.2003.12.001     Document Type: Review

References (55)

1. Veasy L.G. Wiedmeier S.E. Orsmond G.S. Ruttenberg H.D. Boucek M.M. Roth S.J. Resurgence of acute rheumatic fever in the intermountain area of the U.S N Engl J Med 316 1987 421-427
2. Veasy L.G. Tani L.Y. Hill H.R. Persistence of acute rheumatic fever in the intermountain area of the U.S J Pediatr 124 1994 9-11
3. Wald E.R. Dashefsky B. Feidt C. Chiponis D. Byers C. Acute rheumatic fever in Western Pennsylvania and the tri-state area Pediatrics 80 1987 371-374
4. Zangwill K.M. Wald E.R. Londino A.V. Acute rheumatic fever in Western Pennsylvania: a persistent problem into the 1990's J Pediatr 118 1991 561-563
5. Homer C. Shulman S.T. Clinical aspects of acute rheumatic fever J Rheumatol 18 Suppl 29 1991 2-13
6. Vendsborg P. Fauerholdt L. Olsen K.H. Decreasing incidence of a history of acute rheumatic fever in chronic rheumatic heart disease Cardiology 53 1968 332-340
7. Massell B.F. Chute C.G. Walker A.M. Kurland G.S. Penicillin and the marked decrease in morbidity and mortality from rheumatic fever in the United States N Engl J Med 318 1988 280-286
8. Lennon D. Acute rheumatic fever. In: Feigin R.D. Cherry J.D. (Eds.), Textbook of pediatric infectious disease 1998 371-384 WB Saunders Co Philadelphia
9. Oyoo G.O. Ogola E.N. Clinical and socio demographic aspects of congestive heart failure patients at Kenyatta National Hospital, Nairobi East Afr Med J 76 1999 23-27
10. Pereira A.C. Cuce M.R. Wajngarten M. Insuficiencia cardiaca em grande Hospital terciario de Sao Paulo Arq Bras Cardiol 71 1998 15-20
11. Mendez G.F. Cowie M.R. The epidemiological features of heart failure in developing countries: a review of the literature Int J Cardiol 80 2001 213-219
12. Centers for Disease Control Prevention Acute rheumatic fever among army trainees: Fort Leonard Wood, Missouri, 1987-88 Morb Mortal Wkly Rep 37 1988 519-522
13. Wallace M.R. Garst P.D. Papadimos T.J. Oldfield E.C. The return of rheumatic fever in young adults JAMA 262 1989 2557-2561
14. Jones T.D. The diagnosis of rheumatic fever JAMA 126 1944 481-484
15. American Heart Association Guidelines for the diagnosis of rheumatic fever: Jones Criteria, 1992 update: Guidelines for diagnosis of rheumatic fever JAMA 268 1992 2069-2070
16. Svartman M. Potter E.V. Poon-King T. Immunoglobulin components in synovial fluids of patients with acute rheumatic fever J Clin Invest 56 1975 111-117
17. Yoshida K. Yoshikawa J. Shakudo M. Akasaka T. Jyo Y. Takao S. Color Doppler evaluation of valvular regurgitation in normal subjects Circulation 78 1988 840-847
18. Ferrieri P. Jones criteria working group Proceedings of the Jones criteria workshop Circulation 106 2002 2521-2523
19. Gerber M.A. Nonsuppurative post-streptococcal disease: rheumatic fever and acute glomerulonephritis. In: Long S.S. Pickering L.K. Prober C.G. (Eds.), Principles and practices of pediatric infectious diseases 2003 719-725 Churchill Livingstone Philadelphia
20. Bronze M.S. Dale J.B. Epitopes of streptococcal M proteins that evoke antibodies that cross-react with human brain J Immunol 151 1993 2820-2828
21. Husby G. van de Rijn I. Zabreskie J.B. Abdin A.H. Williams R.C. Antibodies reacting with cytoplasm of subthalamic and caudate nuclei neurons in chorea and acute rheumatic fever J Exp Med 144 1976 1094-1110
22. Feinstein A.R. DiMassa R. Prognostic significant of valvular involvement in acute rheumatic fever N Engl J Med 260 1959 1001-1007
23. Kaplan E.L. Top F.H. Dudding B.A. Wannamaker L.W. Diagnosis of streptococcal pharyngitis: Differentiation of acute infection from the carrier state in the symptomatic child J Infect Dis 123 1971 490-501
24. Stollerman G.H. Lewis A.J. Schultz I. Taranta A. Relationship of immune response to group A streptococci to the course of acute, chronic, and recurrent rheumatic fever Am J Med 20 1956 163-169
25. Dajani A. Taubert K. Ferrieri P. Peter G. Shulman S. Treatment of acute streptococcal pharyngitis and prevention of rheumatic fever: a statement for health professionals: Committee on rheumatic fever, endocarditis, and Kawasaki disease of the council on cardiovascular disease in the young American Heart Association. Pediatrics 96 1995 758-764
26. Kaplan M.H. Bolande R. Rakaita L. Blair J. Presence of bound immunoglobulins and complement in the myocardium in acute rheumatic fever N Engl J Med 271 1964 637-645
27. Raizada V. Williams R.C. Chopra P. Gopinath N. Prakash K. Sharma K.B. Tissue distribution of lymphocytes in rheumatic heart valves as defined by monoclonal anti-T cell antibodies Am J Med 74 1983 90-96
28. Wilson M.G. Schweitzer M.D. Lubschez R. The familial epidemiology of rheumatic fever J Pediatr 22 1943 461-491
29. Taranta A. Torosdag S. Metrakos J.D. Rheumatic fever in monozygotic and dizygotic twins Circulation 20 1959 778-792
30. Guedez Y. Kotby A. El-Demellaway M. Galal A. Thompson G. Zaher S. HLA class II associations with rheumatic heart disease are more evident and consistent among clinically homogenous patients Circulation 99 1999 2784-2790
31. Debaz H. Olivo A. Perez-Luque E. Vasquez-Garcia N. Burguete A. Chavez-Negrete A. et al. DNA analysis of HLA class II alleles in rheumatic heart disease in Mexicans Hum Immunol 49 Suppl. 1 1996 63
32. Maharaj B. Hammond G. Appadoo B. Leary W.P. Pudifin D.J. HLA A, B, DR and DQ antigens in black patients with severe chronic rheumatic heart disease Circulation 76 1987 259-261
33. Koyonagi T. Koga Y. Nishi H. Toshima H. Sasazuki T. Imaizumi T. et al. DNA typing of HLA class II genes in Japanese patients with rheumatic heart disease J Mol Cell Cardiol 28 1996 1349-1353
34. Ayoub E.M. Barret D.J. Maclaren N.K. Krischer J.P. Association of class II human histocompatibility leukocyte antigens with rheumatic fever J Clin Invest 77 1986 2019-2026
35. Patarroyo M.E. Winchester R.J. Vejerano A. Gibofsky A. Chalem F. Zabriske J.B. et al. Association of a B-cell alloantigen with susceptibility to rheumatic fever Nature 278 1979 173-174
36. Khanna A.K. Buskirk D.R. Williams R.C. Gibofsky A. Crow M.K. Menon A. et al. Presence of a non-HLA B cell antigen in rheumatic fever patients and their families as defined by a monoclonal antibody J Clin Invest 83 1989 1710-1716
37. Kaur S, Kumar D, Grover A, Khanduja KL, Kaplan EL, Gray ED, et al. Ethnic differences in expression of susceptibility marker(s) in rheumatic fever/rheumatic heart disease patients Int J Cardiol 64 1998 9-14
38. Cunningham M.W. Pathogenesis of Group A streptococcal infections Clin Microbiol Rev 13 3 2000 470-511
39. Liao L. Sindhwani R. Rojkind M. Factor S. Leinwand L. Diamond B. Antibody-mediated autoimmune myocarditis depends on genetically determined target organ sensitivity J Exp Med 181 3 1995 1123-1131
40. Wannamaker L.W. Differences between streptococcal infections of the throat and of the skin N Engl J Med 282 1970 78-85
41. Kaplan E.L. Johnson D.R. Cleary P.P. Group A streptococcal serotypes isolated from patients and sibling contacts during the resurgence of rheumatic fever in the United States in the mid-1990s J Infect Dis 159 1 1989 101-103
42. Stollerman G.H. Rheumatic fever in the 21st century Clin Infect Dis 33 2001 806-814
43. Frank P.F. Stollerman G.H. Miller L.F. Protection of a military population from rheumatic fever JAMA 193 1965 775-783
44. Martin D.R. Voss L.M. Walker S.J. Lennon D. Acute rheumatic fever in Auckland, New Zealand: spectrum of associated group A streptococci different from expected Pediatr Infect Dis 167 1994 1112-1117
45. Smoot J.C. Korgenski E.K. Daly J.A. Veasy L.G. Musser J.M. Molecular analysis of Group A streptococcus type emm 18 isolates temporally associated with acute rheumatic fever outbreaks in Salt Lake City, Utah J Clin Microbiol 40 5 2002 1805-1810
46. Bessen D. Jones K.F. Fischetti V.A. Evidence for two distinct classes of streptococcal M protein and their relationship to rheumatic fever J Exp Med 169 1989 269-283
47. Bessen D.E. Veasy G. Hill H.R. Augustine N.H. Fischetti V.A. Serologic evidence for a Class I group A streptococcal infection among rheumatic fever patients J Infect Dis 172 1995 1608-1611
48. Dinkla K. Rohde M. Jansen W. Kaplan E.L. Chhatwal G.S. Talay S.R. Rheumatic fever-associated Streptococcus pyogenes isolates aggregate collagen J Clin Invest 111 2003 1905-1912
49. Smoot J.C. Barbian K.D. Van Gompel J.J. Smoot L.M. Chausee M.S. et al. Genome sequence and microarray analysis of serotype M18 group A streptococcus strains associated with acute rheumatic fever outbreaks Proc Natl Acad Sci USA 99 7 2002 4668-4673
50. Yinduo J. Carlson B. Kondagunta A. Cleary P.P. Intranasal immunization with C5a peptidase prevents nasopharyngeal colonization of mice by the Group A streptococcus Infect Immun 65 6 1997 2080-2087
51. Lancefield R.C. Persistence of type-specific antibodies in man following infection with Group A streptococci J Exp Med 110 1959-271
52. Dale J.B. Beachey E.H. Protective antigenic determinant of streptococcal M protein shared with sarcolemmal membrane protein of human heart J Exp Med 156 1982 1165-1176
53. Dale J.B. Beachey E.H. Multiple, heart-cross reactive epitopes of streptococcal M proteins J Exp Med 161 1985 113-122
54. Hu M.C. Walls M.A. Stroop S.D. Reddish M.A. Beall B. Dale J.B. Immunogenicity of a 26-valent Group A streptococcal vaccine Infect Immun 70 4 2002 2171-2177
55. Dale J.B. Group A streptococcal vaccines Infect Dis Clin North Am 13 1 1999 227-243